|
GTEX-132Q8
|
61-70
|
Male
|
GTEX-132Q8-0326 |
Adipose tissue
|
PAXgene |
1
|
2 pieces; 5-10% fibrous and vascular tissue
|
Acceptable
|
 |
|
GTEX-132Q8
|
61-70
|
Male
|
GTEX-132Q8-1426 |
Mammary tissue (breast)
|
PAXgene |
1
|
2 pieces; gynecomastoid change
|
Acceptable
|
 |
|
GTEX-132QS
|
61-70
|
Male
|
GTEX-132QS-1126 |
Prostate
|
PAXgene |
1
|
2 pieces, glands well preserved; one aliquot is ~50% 'capsule' and fibrous tissue, glandular portion delineated
|
Acceptable
|
 |
|
GTEX-132QS
|
61-70
|
Male
|
GTEX-132QS-1326 |
Mammary tissue (breast)
|
PAXgene |
1
|
2 pieces, mainly fibroadipose tisssue; a few ductal elements noted, rep. delineated
|
Acceptable
|
 |
|
GTEX-132QS
|
61-70
|
Male
|
GTEX-132QS-2526 |
Adipose tissue
|
PAXgene |
0
|
2 pieces, minimal fascia/fibrous tissue, good specimens
|
Acceptable
|
 |
|
GTEX-1339X
|
41-50
|
Male
|
GTEX-1339X-1526 |
Ileum
|
PAXgene |
1
|
6 pieces; only 1 piece contains lymphoid tissue; better suited for LCM
|
Unacceptable
|
 |
|
GTEX-1339X
|
41-50
|
Male
|
GTEX-1339X-2026 |
Prostate
|
PAXgene |
1
|
2 pieces; 1 is mainly prostatic urethra and periurethral ducts; other contains skeletal muscle and fibrous tissue
|
Unacceptable
|
 |
|
GTEX-1339X
|
41-50
|
Male
|
GTEX-1339X-2126 |
Mammary tissue (breast)
|
PAXgene |
0
|
2 pieces; fibrofatty tissue without ducts
|
Acceptable
|
 |
|
GTEX-1339X
|
41-50
|
Male
|
GTEX-1339X-2226 |
Skin, leg
|
PAXgene |
0
|
6 pieces; all contain excessive subcutaneous fat up to 3 mm thick; (note that 26 tissue trimmed)
|
Acceptable
|
 |
|
GTEX-1339X
|
41-50
|
Male
|
GTEX-1339X-2526 |
Adipose tissue
|
PAXgene |
0
|
2 pieces; 20% fibrovascular content
|
Acceptable
|
 |
|
GTEX-133LE
|
21-40
|
Female
|
GTEX-133LE-1726 |
Mammary tissue (breast)
|
PAXgene |
0
|
2 pieces; 1 with ducts & lobules; 1 with >90% fat
|
Acceptable
|
 |
|
GTEX-133LE
|
21-40
|
Female
|
GTEX-133LE-1926 |
Adipose tissue
|
PAXgene |
0
|
2 pieces; 20% fibrous content in 1, 5% in other
|
Acceptable
|
 |
|
GTEX-1399Q
|
41-50
|
Male
|
GTEX-1399Q-0626 |
Adipose tissue
|
PAXgene |
1
|
2 pieces; fat with 20% and 10% fibrous tissue/tendon
|
Acceptable
|
 |
|
GTEX-1399Q
|
41-50
|
Male
|
GTEX-1399Q-0926 |
Mammary tissue (breast)
|
PAXgene |
1
|
2 pieces; adipose tissue with fibrovascular component only
|
Acceptable
|
 |
|
GTEX-1399Q
|
41-50
|
Male
|
GTEX-1399Q-2226 |
Ileum
|
PAXgene |
2
|
4 pieces; fragments of autolyzed mucosa, muscularis, and fat; no lymphoid tissue
|
Unacceptable
|
 |
|
GTEX-1399R
|
21-40
|
Male
|
GTEX-1399R-1426 |
Mammary tissue (breast)
|
PAXgene |
1
|
2 pieces; fibroadipose tissue with ducts
|
Acceptable
|
 |
|
GTEX-1399R
|
21-40
|
Male
|
GTEX-1399R-2626 |
Adipose tissue
|
PAXgene |
1
|
2 pieces
|
Acceptable
|
 |
|
GTEX-1399S
|
21-40
|
Female
|
GTEX-1399S-0426 |
Adrenal glands
|
PAXgene |
1
|
2 pieces all cortex, rim of fibrous tissue up to ~0.5mm, delineated
|
Acceptable
|
 |
|
GTEX-1399S
|
21-40
|
Female
|
GTEX-1399S-1126 |
Mammary tissue (breast)
|
PAXgene |
0
|
2 pieces, marked stromal fibrous mastopathy, rare ductal/lobular elements, atrophic for age
|
Acceptable
|
 |
|
GTEX-1399S
|
21-40
|
Female
|
GTEX-1399S-1426 |
Omentum
|
PAXgene |
1
|
2 pieces, ~10% vascular/fibrous tissue
|
Acceptable
|
 |
|
GTEX-1399S
|
21-40
|
Female
|
GTEX-1399S-2026 |
Ileum
|
PAXgene |
1
|
6 pieces, ~well preserved, lymphoid/Peyer aggregates are up to ~40% total tissue
|
Acceptable
|
 |
|
GTEX-1399S
|
21-40
|
Female
|
GTEX-1399S-2526 |
Adipose tissue
|
PAXgene |
0
|
2 pieces ~10-15% fascial/fibrous tissue, rep. delineated
|
Acceptable
|
 |
|
GTEX-1399T
|
61-70
|
Male
|
GTEX-1399T-0226 |
Mammary tissue (breast)
|
PAXgene |
1
|
2 pieces; fibroadipose tissue and mammary ducts with periductal lymphocytic infiltrate and stromal fibrosis/hyalinization
|
Acceptable
|
 |
|
GTEX-1399T
|
61-70
|
Male
|
GTEX-1399T-2726 |
Adipose tissue
|
PAXgene |
1
|
2 pieces
|
Acceptable
|
 |
|
GTEX-1399U
|
41-50
|
Female
|
GTEX-1399U-1826 |
Mammary tissue (breast)
|
PAXgene |
1
|
2 pieces, ductal lobular elements well-represented, delineated; lobular hyperplasia/atypical hyperplasia noted focally, ensquared
|
Acceptable
|
 |